Timothy A. Springer - Mar 26, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol: RNAC
Transactions as of: Mar 26, 2024
Transactions value $: $2,876,847
Form type: 4
Date filed: 3/26/2024, 04:32 PM
Previous filing: Mar 20, 2024
Next filing: Apr 10, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Common Stock	Options Exercise	$2.88M	+1.97M	+6.34%	$1.46	33M	Mar 26, 2024	See Footnote	F1
holding	RNAC	Common Stock						7.47M	Mar 26, 2024	Direct
holding	RNAC	Common Stock						86.4K	Mar 26, 2024	By wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNAC	Warrant (Right to Buy)	Options Exercise	$0	-1.97M	-100%	$0.00^*	0	Mar 26, 2024	Common Stock	1.97M	$1.46	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.